Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v10-FR
Language English French
Date Updated 2023-03-10 2023-01-10
Drug Identification Number 02284448 02284448
Brand name TARO-PRAVASTATIN TARO-PRAVASTATIN
Common or Proper name PRAVASTATIN PRAVASTATIN
Company Name SUN PHARMA CANADA INC SUN PHARMA CANADA INC
Ingredients PRAVASTATIN SODIUM PRAVASTATIN SODIUM
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-08-23 2022-08-23
Estimated end date 2023-03-31 2023-03-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments